Kaye David M, Stub Dion, Mak Vivian, Doan Tuan, Duffy Stephen J
Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia; Heart Failure Research Group, Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
Catheter Cardiovasc Interv. 2014 Apr 1;83(5):741-5. doi: 10.1002/ccd.25348. Epub 2014 Jan 7.
To evaluate the impact of a device-mediated modification of the injection pressure profile on iodinated contrast volumes during coronary angiography and percutaneous coronary intervention (PCI).
The development of iodinated contrast-induced acute kidney injury (AKI) is associated with significant morbidity and mortality in patients undergoing coronary angiography and intervention, particularly in the setting of ST-elevation myocardial infarction. Iodinated contrast volume is a recognized risk factor for iodinated contrast-induced AKI. Mitigation of iodinated contrast loss due to coronary iodinated contrast reflux represents a potential means to reduce iodinated contrast volume.
We assessed the effectiveness of injection pressure modulation using an iodinated contrast conservation system (CCS), in 21 patients undergoing diagnostic coronary angiography or PCI. System activation was associated with a marked reduction in iodinated contrast injection compared with standard imaging (3.5 ± 1.1 vs. 5.4 ± 1.7 mL, P < 0.001). Paired images were obtained in 59 instances with significantly less iodinated contrast use with CCS use (3.3 ± 1.1 vs. 5.5 ± 1.6 mL, P < 0.001), with comparable image quality in 98% of cases.
Modulation of iodinated contrast injection pressure provides a novel potential means to reduce iodinated contrast volumes by attenuating inefficient losses due to ostial reflux. Future studies are required to define the ability of the CCS to reduce total iodinated contrast volume and to impact upon the risk of iodinated contrast-induced AKI.
评估在冠状动脉造影和经皮冠状动脉介入治疗(PCI)过程中,一种设备介导的注射压力曲线改变对碘化造影剂用量的影响。
在接受冠状动脉造影和介入治疗的患者中,尤其是在ST段抬高型心肌梗死的情况下,碘化造影剂诱发的急性肾损伤(AKI)的发生与显著的发病率和死亡率相关。碘化造影剂用量是碘化造影剂诱发AKI的一个公认危险因素。减轻因冠状动脉碘化造影剂反流导致的碘化造影剂损失是减少碘化造影剂用量的一种潜在方法。
我们评估了在21例接受诊断性冠状动脉造影或PCI的患者中,使用碘化造影剂保存系统(CCS)进行注射压力调节的有效性。与标准成像相比,系统激活与碘化造影剂注射量显著减少相关(3.5±1.1 vs. 5.4±1.7 mL,P<0.001)。在59例情况下获得了配对图像,使用CCS时碘化造影剂用量显著减少(3.3±1.1 vs. 5.5±1.6 mL,P<0.001),98%的病例图像质量相当。
调节碘化造影剂注射压力提供了一种新的潜在方法,通过减少因开口处反流导致的无效损失来降低碘化造影剂用量。未来需要开展研究来确定CCS减少总碘化造影剂用量的能力以及对碘化造影剂诱发AKI风险的影响。